[go: up one dir, main page]

MX2018001117A - Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna. - Google Patents

Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna.

Info

Publication number
MX2018001117A
MX2018001117A MX2018001117A MX2018001117A MX2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A MX 2018001117 A MX2018001117 A MX 2018001117A
Authority
MX
Mexico
Prior art keywords
infants
lnnt
inducing
nutritional compositions
gut microbiota
Prior art date
Application number
MX2018001117A
Other languages
English (en)
Other versions
MX379149B (es
Inventor
Sprenger Norbert
Berger Bernard
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53773387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2018001117(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018001117A publication Critical patent/MX2018001117A/es
Publication of MX379149B publication Critical patent/MX379149B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/08—Deoxysugars; Unsaturated sugars; Osones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una composición nutricional que comprende al menos un oligosacárido fucosilado y al menos un oligosacárido N-acetilado para promover o inducir una microbiota intestinal global más cercana a la de los infantes alimentados exclusivamente con leche materna humana, en comparación con los infantes alimentados con una composición nutricional convencional. La composición puede ser una fórmula para infantes y, en particular, está destinada a infantes de entre 0 y 12 meses alimentados predominantemente con fórmula para infantes. Promueve una flora intestinal saludable y tiene efectos beneficiosos a corto y largo plazo.
MX2018001117A 2015-08-04 2016-08-04 Composiciones nutricionales con 2fl y lnnt para usar en la inducción de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna. MX379149B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15179742 2015-08-04
PCT/EP2016/068597 WO2017021476A1 (en) 2015-08-04 2016-08-04 Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants

Publications (2)

Publication Number Publication Date
MX2018001117A true MX2018001117A (es) 2018-04-20
MX379149B MX379149B (es) 2025-03-10

Family

ID=53773387

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001117A MX379149B (es) 2015-08-04 2016-08-04 Composiciones nutricionales con 2fl y lnnt para usar en la inducción de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna.

Country Status (9)

Country Link
US (1) US20180220690A1 (es)
EP (1) EP3331534B1 (es)
CN (1) CN107847509B (es)
AU (1) AU2016303000B2 (es)
ES (1) ES2772685T3 (es)
MX (1) MX379149B (es)
PH (1) PH12017502350A1 (es)
RU (1) RU2724590C2 (es)
WO (1) WO2017021476A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3212012A1 (en) 2014-10-31 2017-09-06 Nestec S.A. Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
RU2731067C2 (ru) * 2015-03-05 2020-08-28 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
ES2947458T3 (es) * 2015-03-05 2023-08-09 Nestle Sa Composiciones para su uso en la prevención o el tratamiento de infecciones gastrointestinales en lactantes o niños pequeños
EP3509438B1 (en) * 2016-09-07 2025-01-22 Société des Produits Nestlé S.A. Nutritional compositions for infants and/or young children comprising oligosaccharides
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
US11278558B2 (en) 2017-03-01 2022-03-22 Glycom A/S Synthetic composition for microbiota modulation
US20180333426A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
WO2019008102A1 (en) * 2017-07-07 2019-01-10 Nestec S.A. FORTIFYING HUMAN MILK
WO2019122178A1 (en) 2017-12-21 2019-06-27 Societe Des Produits Nestle S.A. Compositions comprising at least on n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
EP3749328A1 (en) 2018-02-09 2020-12-16 N.V. Nutricia Fermented formula with non-digestible oligosaccharides
CN112384227A (zh) 2018-02-09 2021-02-19 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
GB2573538B (en) * 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
FR3099770B1 (fr) * 2019-08-05 2023-01-13 Luxia Scient Methode d’analyse de la perte de diversite bacterienne du microbiome intestinal humain
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN111437282A (zh) * 2020-04-28 2020-07-24 南开大学 2′-岩藻糖基乳糖减少大肠杆菌o157在体内定殖的应用
JP2023545766A (ja) * 2020-10-16 2023-10-31 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳児又は低年齢の小児用フォーミュラ
JP2023546794A (ja) * 2020-10-28 2023-11-08 ディーエスエム アイピー アセッツ ビー．ブイ． 抗生物質に曝露した後で腸内マイクロバイオームのバランス回復のためのビタミンの直接的送達
CN114504109B (zh) * 2020-11-16 2024-02-09 内蒙古伊利实业集团股份有限公司 一种含乳双歧杆菌与母乳低聚糖的组合物及其应用
CN112514997B (zh) * 2020-11-30 2022-03-11 内蒙古伊利实业集团股份有限公司 改善肠道微环境健康的母乳低聚糖及其应用
CN113796546A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 改善肠道屏障功能母乳低聚糖组合物及其应用
CN116439377A (zh) * 2023-04-21 2023-07-18 合生元（广州）健康产品有限公司 一种用于缓解婴幼儿菌群失调的营养组合物及其用途
CN117223848A (zh) * 2023-09-22 2023-12-15 黑龙江飞鹤乳业有限公司 适用于早产儿的粉末状营养组合物及其制备方法
DK202430092A1 (en) 2024-02-23 2025-08-29 Dsm Ip Assets Bv Hmo mixture and its use in reducing c. difficile toxins
WO2025196272A1 (en) * 2024-03-22 2025-09-25 Dsm Ip Assets B.V. Combination of mixtures of hmos with mfgm and their use
WO2025242902A1 (en) 2024-05-24 2025-11-27 N.V. Nutricia Oligosaccharide mixture for brain development
WO2026013110A1 (en) * 2024-07-10 2026-01-15 Société des Produits Nestlé S.A. A mixture of human milk oligosaccharides

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US5906982A (en) 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
AU2007225549B2 (en) * 2006-03-10 2012-09-27 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
MX2010005132A (es) * 2007-11-08 2010-06-02 Nestec Sa Uso de oligosacaridos conteniendo n-acetilactosamina para maduración de las respuestas inmunes en neonatos.
WO2009082214A1 (en) 2007-12-21 2009-07-02 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
CA2725051A1 (en) * 2008-05-27 2009-12-03 Nestec S.A. Probiotics to improve gut microbiota
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
SG10201707519PA (en) * 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MX376863B (es) 2010-12-31 2025-03-07 Abbott Lab Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o niños al usar los oligosacaridos de leche humana.
BR112013016914A2 (pt) * 2010-12-31 2019-09-24 Abbott Lab combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica
CA2835989A1 (en) 2011-05-13 2012-11-22 Glycom A/S Diversification of human milk oligosaccharides (hmos) or precursors thereof
EP2522232A1 (en) 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
JP6129821B2 (ja) 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
PH12014500443A1 (en) * 2011-10-18 2014-04-14 Socia‰Ta‰ Des Produits Nestla‰ S A Composition for use in brain growth and/or cognitive and/or psychomotor development
MY167583A (en) * 2011-11-10 2018-09-20 Nestec Sa Infant formula with high sn-2 palmitate and oligofructose
WO2013185780A1 (en) 2012-06-14 2013-12-19 Glycom A/S Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or blends thereof
AU2014350157A1 (en) * 2013-11-15 2016-04-14 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
ES2916813T3 (es) * 2013-11-15 2022-07-06 Nestle Sa Composiciones para uso en la prevención o tratamiento de enterocolitis necrotizante en lactantes y niños pequeños
US10695358B2 (en) * 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
RU2731067C2 (ru) * 2015-03-05 2020-08-28 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста

Also Published As

Publication number Publication date
ES2772685T3 (es) 2020-07-08
RU2018107583A3 (es) 2019-12-05
US20180220690A1 (en) 2018-08-09
PH12017502350A1 (en) 2018-06-25
EP3331534B1 (en) 2019-12-18
MX379149B (es) 2025-03-10
WO2017021476A1 (en) 2017-02-09
EP3331534A1 (en) 2018-06-13
AU2016303000B2 (en) 2021-01-21
RU2724590C2 (ru) 2020-06-25
CN107847509A (zh) 2018-03-27
CN107847509B (zh) 2021-06-01
RU2018107583A (ru) 2019-09-05
AU2016303000A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
MX2018001117A (es) Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna.
MX2018015187A (es) Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
MX2018000958A (es) Composiciones nutritivas y formulas infantiles que comprenden bifidobacterium animalis ssp.lactis y, opcionalmente, una mezcla de oligosacaridos para inducir una microbiota intestinal cercana a la de un infante alimentado por lactancia materna.
MX377225B (es) Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene.
MX2017010922A (es) Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2016006220A (es) Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
BR112013024199A2 (pt) métodos para melhorar a saúde óssea em bebês usando prebióticos
MX2017010924A (es) Composiciones para uso en la prevencion o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
MX382069B (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños.
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
AR104835A1 (es) Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas
PH12016500774A1 (en) Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
MX2018009015A (es) Oligosacaridos de la leche humana para beneficios de la salud mediante la prevencion del rebote adiposo precoz.
PH12017500202A1 (en) Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses
CL2022001526A1 (es) Composiciones que comprenden oligosacáridos de la leche humana para uso en un sujeto para apoyar
TR201908639T4 (tr) Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler.
CL2015001254A1 (es) Composición quelante de arsénico.
BR112016018009A8 (pt) composição de cinamaldeído e zinco e seu uso
BR112018009381A2 (pt) suplemento alimentar compreendendo beta-glucano e hidrolisado de caseína para melhora da saúde e desempenho de crescimento em um mamífero
BR112017009743A2 (pt) produto de bebida com tartarato de sódio e potássio